Cigna
S&P 500
$280.76
-0.05%
Delayed · cached 15 min
Peer comparison
| Company | Price↕ | Market Cap↕ | P/E↕ | P/B↕ | ROE %↕ | ROCE %↕ | Div yield %↕ | Valuation |
|---|---|---|---|---|---|---|---|---|
| CVS Health | $ 94.66 | $121.07B | 24.98 | 1.52 | 2.22 | 2.82 | 2.79 | Above FV |
| Cigna | $ 280.76 | $74.19B | 11.62 | 1.74 | 13.98 | 9.13 | 2.19 | Below FV |
| Quest Diagnostics | $ 235.02 | $25.94B | 24.95 | 3.44 | 13.20 | 10.61 | 1.44 | Above FV |
| Labcorp | $ 311.54 | $25.27B | 25.77 | 2.93 | 10.18 | 8.81 | 0.94 | Above FV |
| DaVita | $ 181.55 | $11.58B | 15.39 | -15.18 | -97.61 | 14.03 | 0.00 | — |
| BrightSpring Health Services, Inc. | $ 58.73 | $11.62B | 52.44 | 5.91 | 9.31 | 7.14 | 0.00 | Above FV |
| Progyny | $ 27.35 | $2.10B | 29.73 | 4.63 | 12.91 | 16.61 | 0.00 | Above FV |
| Chemed Corp. | $ 515.97 | $6.74B | 25.98 | 8.09 | 31.94 | 26.17 | 0.47 | Above FV |
| Hims & Hers Health | $ 27.51 | $6.42B | 53.94 | 19.81 | 39.61 | 3.28 | 0.00 | Above FV |
| RadNet, Inc. | $ 75.49 | $5.94B | -301.96 | 5.49 | -1.70 | 1.70 | 0.00 | — |
| Sotera Health | $ 18.37 | $5.24B | 32.23 | 7.87 | 11.71 | 4.82 | 0.00 | Above FV |
| Concentra Group Holdings Parent, Inc. | $ 34.95 | $4.46B | 22.55 | 9.34 | 34.88 | 12.49 | 0.73 | Above FV |
Price, market cap, P/E, P/B and dividend yield reflect the live quote (delayed, cached 15 min); ROE/ROCE from reported financials. The highlighted row is the current company. Click a column header to sort. Educational data only.
How to read the peer comparison
This table places the company beside others in the same industry on a few common measures. Comparison adds context that a single company's numbers cannot give on their own.
- Valuation multiples like P/E and P/B are most meaningful within the same industry, because different industries naturally trade at different levels. Comparing a company only to its peers is more useful than to the whole market.
- Return measures (ROE, ROCE) show how efficiently each company turns capital into profit. A company well ahead of or behind its peers here is worth understanding.
- No single column decides anything. A beginner reads the row across — valuation, returns, and size together — and treats the highlighted current company as one data point among its peers.
- Use the sortable headers to rank peers on any measure, but remember that "cheaper" or "higher" on one metric is a starting question, not an answer.
Educational only — not a recommendation to buy, sell, or hold any security.